Perioperative Chemotherapy for Gastric Cancer: How Should We Measure the Efficacy?

By Persiani Roberto  

Annals of Surgical Oncology, Vol. 16, Iss. 4, 2009-04 ,pp. : 1077-1079

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use?

By Kasimir-Bauer S.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 123-132

Springer Publishing Company

Access to resources Recommend Favorite

Perioperative Chemotherapy for Gastric Cancer

By Catarci Marco  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1253-1253

Springer Publishing Company

Access to resources Recommend Favorite

Is there a role for ovarian function suppression in operable breast cancer?

By Sparano Joseph  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 311-313

Springer Publishing Company

Access to resources Recommend Favorite

Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trial

By Songun I.   Keizer H.J.   Hermans J.   Klementschitsch P.   de Vries J.E.   Wils J.A.   van der Bijl J.   van Krieken J.H.J.M.   van de Velde C.J.H.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 558-562

Elsevier

Access to resources Recommend Favorite